The science of success

The Science of Success

BIA response to the Science and Technology Committee's inquiry on UK ARPA

The BIA has responded to the Science and Technology Committee’s inquiry on a UK Advanced Research Projects Agency (ARPA).

Influencing and shaping our sector | BIA update: October 2020 - January 2021

This quarterly update gives an overview of key policy developments and the BIA’s continued engagement with policymakers, regulatory authorities and wider stakeholders on behalf of the UK life sciences sector, from October 2020 to January 2021.

BIA submission to the Lord Hill review of UK listing rules

The BIA has written to Lord Hill responding to his call for evidence on the UK's listing rules. 

BIA response to the National Security and Investment Bill

BIA submission to Budget 2021

The BIA has submitted to the Government's call for views ahead of the Budget on 3 March 2021.

UK quoted biotech performance and investor base in 2020

This report is an exclusive analysis of the performance of the UK-quoted biotech sector and the breadth of its investor base by Radnor Capital Partners on behalf of the BIA.

BIA submission to the DWP consultation on improving outcomes for members of DC schemes

BIA submission to the HMT consultation on the scope of R&D tax credits

The BIA has responded to the HM Treasury and HMRC consultation on the scope of qualifying expenditure for R&D tax credits. 

BIA submission to the IPO consultation on AI and IP

The BIA has responded to the UK Intellectual Property Office's call for views on AI and IP.